Skip to main content
Veterinary Medicines

HIPRAGUMBORO CW Lyophilisate for use in drinking water

Authorised
  • Infectious bursal disease virus, strain CH/80, Live

Product identification

Medicine name:
HIPRAGUMBORO CW Lyophilisate for use in drinking water
HIPRA GUMBORO CW liofilizāts lietošanai ar dzeramo ūdeni
Active substance:
  • Infectious bursal disease virus, strain CH/80, Live
Target species:
  • Chicken (broiler)
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain CH/80, Live
    31622800.00
    50% cell culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken (broiler)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD09
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:
  • box containing 1 vial of 10000 doses
  • box containing 1 vial of 5000 doses
  • box containing 1 vial of 1000 doses
  • box containing 10 vials of 10000 doses
  • box containing 10 vials of 1000 doses
  • box containing 10 vials of 5000 doses

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Laboratorios Hipra S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratorios Hipra S.A.
Responsible authority:
  • Food And Veterinary Service
Authorisation number:
  • V/MRP/18/0044
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0162/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Estonia
  • France
  • Germany
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Slovakia
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Combined File of all Documents

English (PDF)
Published on: 24/07/2025
Download
Latvian (PDF)
Published on: 7/03/2024